Results 181 to 190 of about 274,173 (312)

Supplementary Figure 8 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer

, 2023
Biagio Ricciuti, Arielle Elkrief, Joao V. Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M. Muldoon, Arrien A. Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R. Vaz, Malini Gandhi, Elinton Lee, Geoffrey I. Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D. Felt, Bijaya Sharma, Andrew D. Cherniack, Scott J. Rodig, Daniel R. Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A. Jänne, Adam J. Schoenfeld, Lynette M. Sholl, Mark M. Awad, Michael L. Cheng   +32 more
openalex   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

Molecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Current landscape of cancer genomics research in sub-Saharan Africa - a review of literature. [PDF]

Front Oncol
Amaeshi LC, Okunade KS, Anorlu RI.
europepmc   +1 more source

Bioinformatics roadmap for therapy selection in cancer genomics. [PDF]

Mol Oncol, 2022
Jiménez-Santos MJ, García-Martín S, Fustero-Torre C, Di Domenico T, Gómez-López G, Al-Shahrour F.   +5 more
europepmc   +1 more source

Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer

, 2015
Thomas S. Frank, Xiaotian Sun, Yuqing Zhang, Jingxuan Yang, William E. Fisher, Marie‐Claude Gingras, Min Li   +6 more
openalex   +1 more source

Supplementary Data S10 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

, 2023
Naoual Menssouri, Loïc Poiraudeau, Carole Hélissey, Ludovic Bigot, Jonathan Sabio, Tony Ibrahim, Cédric Pobel, Claudio Nicotra, Maud Ngo‐Camus, Ludovic Lacroix, Étienne Rouleau, Lambros Tselikas, Anne Chauchereau, Félix Blanc‐Durand, Alice Bernard‐Tessier, Anna Patrikidou, Natacha Naoun, Ronan Flippot, Émeline Colomba, Alina Fuerea, Laurence Albigès, Pernelle Lavaud, Paul van de Wiel, Eveline den Biezen, Yvonne Wesseling-Rozendaal, Santiago Ponce, Stefan Michiels, Christophe Massard, Daniel Gautheret, Fabrice Barlési, Fabrice André, Benjamin Besse, Jean‐Yves Scoazec, Luc Friboulet, Karim Fizazi, Yohann Loriot   +35 more
openalex   +1 more source

Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer

Molecular Oncology, EarlyView.
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova, Zuzana Kozovska, Ondrej Pos, Kristina Pavlov, Sachin Gulati, Peter Makovicky, Kristina Jakic, Monika Burikova, Eva Sedlackova, Barbora Svitkova, Silvia Tyciakova, Vojtech Bystry, Nicolas Blavet, Boris Tichy, Matej Hrnciar, Jaroslav Budis, Miroslav Tomas, Peter Dubovan, Georgina Kolnikova, Veronika Repaska, Nikoleta Mojzesova, Eva Zomborska, Daniel Pindak, Michal Mego, Tomas Szemes, Miroslava Matuskova   +25 more
wiley   +1 more source

PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance. [PDF]

Ther Adv Med Oncol
Pilotto S, Belluomini L, Monaca F, Simbolo M, Agostini A, Mafficini A, Golovco S, Sperduti I, Vita E, Stefani A, Carbone C, Piro G, Ferrara MG, Lococo F, Ludovini V, Chiari R, Novello S, Corbo V, Milella M, Scarpa A, Tortora G, Bria E.   +21 more
europepmc   +1 more source

Pancreatic cancer: molecular genomics and clinical applications

, 2016
Shinichi Yachida, Erina Takai
openalex   +2 more sources

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source